Abstract
Retroperitoneal fibrosis (RPF) is a chronic progressive disease process characterized by inflammation and fibrosis in the retroperitoneum that may lead to compression of vital structures, including the ureters. RPF primarily affects patients between 40 and 60 years of age, with an estimated incidence of 1:200,000 to 1:500,000 per year. Most cases are deemed idiopathic with drugs, such as methysergide and other ergot alkaloids, accounting for a significant portion of cases with identifiable causes. In some instances, RPF can be attributed to retroperitoneal malignancies or prior exposure to retroperitoneal radiation therapy.1
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006;367(9506):241-251.
Cronin CG, Lohan DG, Blake MA, et al. Retroperitoneal fibrosis: a review of clinical features and imaging findings. AJR Am J Roentgenol. 2008;191(2):423-431.
van Bommel EF. Retroperitoneal fibrosis. Neth J Med. 2002;60(6):231-242.
Scheel PJ Jr, Piccini J, Rahman MH, et al. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis. J Urol. 2007;178(1):140-143.
Kavoussi LR, Clayman RV, Brunt LM, et al. Laparoscopic ureterolysis. J Urol. 1992;147(2):426-429.
Srinivasan AK, Richstone L, Permpongkosol S, et al. Comparison of laparoscopic with open approach for ureterolysis in patients with retroperitoneal fibrosis. J Urol. 2008;179(5):1875-1878.
Bosl GJ, Bajorin DF, Sheinfeld J. Cancer of the testis. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer, Principles & Practice of Oncology. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005:1491-1518.
Lashley DB, Lowe BA. A rational approach to managing stage I nonseminomatous germ cell cancer. Urol Clin North Am. 1998;25(3):405-423.
Allaf ME, Bhayani SB, Link RE, et al. Laparoscopic retroperitoneal lymph node dissection: duplication of open technique. Urology. 2005;65(3):575-577.
Janetschek G, Hobisch A, Peschel R, et al. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma: long-term outcome. J Urol. 2000;163(6):1793-1796.
Permpongkosol S, Lima GC, Warlick CA, et al. Postchemotherapy laparoscopic retroperitoneal lymph node dissection: evaluation of complications. Urology. 2007;69(2):361-365.
Kenney PA, Tuerk IA. Complications of laparoscopic retroperitoneal lymph node dissection in testicular cancer. World J Urol. 2008;26(6):561-569.
Donohue JP, Thornhill JA, Foster RS, et al. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation. J Urol. 1993;149(2):237-243.
Link RE, Amin N, Kavoussi LR. Chylous ascites following retroperitoneal lymphadenectomy for testes cancer. Nat Clin Pract Urol. 2006;3(4):226-232.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer London
About this chapter
Cite this chapter
Atalla, M.A., Woodard, E.J., Kavoussi, L.R. (2011). Difficulties in Laparoscopic Ureterolysis and Retroperitoneal Lymph Node Dissection. In: Al-Kandari, A., Gill, I. (eds) Difficult conditions in laparoscopic urologic surgery. Springer, London. https://doi.org/10.1007/978-1-84882-105-7_24
Download citation
DOI: https://doi.org/10.1007/978-1-84882-105-7_24
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-104-0
Online ISBN: 978-1-84882-105-7
eBook Packages: MedicineMedicine (R0)